Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Elizabeth McFarland

Concepts (375)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV-1
26
2025
839
2.920
Why?
HIV Infections
48
2025
2729
2.920
Why?
Respiratory Syncytial Virus Vaccines
6
2022
34
2.370
Why?
Respiratory Syncytial Virus Infections
6
2022
120
2.180
Why?
Respiratory Syncytial Virus, Human
6
2022
69
2.160
Why?
Infectious Disease Transmission, Vertical
18
2025
171
2.150
Why?
HIV Antibodies
12
2025
57
2.070
Why?
Anti-Retroviral Agents
12
2023
231
1.750
Why?
Viral Proteins
3
2020
327
1.600
Why?
Antibodies, Viral
8
2022
602
1.140
Why?
Antibodies, Neutralizing
8
2025
265
1.120
Why?
Antibodies, Monoclonal
6
2025
1366
0.900
Why?
Anti-HIV Agents
11
2025
757
0.880
Why?
AIDS Vaccines
8
2018
47
0.870
Why?
Pregnancy Complications, Infectious
8
2016
367
0.780
Why?
Gene Deletion
2
2020
379
0.730
Why?
Breast Feeding
4
2025
424
0.660
Why?
Atazanavir Sulfate
2
2017
41
0.640
Why?
HIV Protease Inhibitors
2
2017
68
0.630
Why?
Ritonavir
2
2017
73
0.620
Why?
Vaccination
6
2020
1348
0.590
Why?
Infant, Newborn
23
2025
5769
0.590
Why?
Vaccines, Attenuated
6
2022
125
0.580
Why?
HIV Envelope Protein gp120
6
2017
57
0.580
Why?
Infant
31
2025
9005
0.530
Why?
Nelfinavir
1
2016
9
0.510
Why?
Lopinavir
1
2016
30
0.500
Why?
Syncope
1
2016
51
0.500
Why?
Patient Dropouts
1
2016
64
0.500
Why?
Bradycardia
1
2016
53
0.500
Why?
Lyme Disease
1
2016
56
0.490
Why?
Health Resources
1
2016
115
0.470
Why?
Infant, Newborn, Diseases
1
2016
111
0.450
Why?
HIV
5
2014
227
0.420
Why?
Patient Compliance
2
2018
567
0.410
Why?
Child
37
2025
20932
0.390
Why?
Immunogenicity, Vaccine
4
2021
27
0.390
Why?
CD4-Positive T-Lymphocytes
2
2017
1058
0.360
Why?
Humans
72
2025
129527
0.360
Why?
T-Lymphocytes, Cytotoxic
4
2005
170
0.360
Why?
Virus Replication
4
2020
453
0.360
Why?
Female
48
2025
68650
0.350
Why?
Lymphocyte Activation
5
2017
1109
0.320
Why?
Male
39
2025
63586
0.310
Why?
Adolescent
27
2025
20409
0.300
Why?
Viral Load
9
2017
449
0.290
Why?
HIV Seropositivity
2
2023
120
0.280
Why?
Bone Density
2
2025
463
0.280
Why?
Double-Blind Method
3
2020
1873
0.270
Why?
RNA, Viral
8
2023
620
0.260
Why?
Antibodies, Bacterial
2
2018
139
0.250
Why?
Dyslipidemias
2
2017
173
0.240
Why?
Antiretroviral Therapy, Highly Active
6
2017
267
0.240
Why?
Bone Development
1
2025
50
0.240
Why?
Immunoenzyme Techniques
1
2005
211
0.230
Why?
Immunoglobulin G
3
2022
851
0.220
Why?
Colonography, Computed Tomographic
1
2024
6
0.220
Why?
Viremia
3
2011
132
0.220
Why?
Diverticulum
1
2024
11
0.220
Why?
Child, Preschool
21
2022
10499
0.220
Why?
Gene Products, gag
2
1994
36
0.210
Why?
Mammography
1
2025
146
0.210
Why?
Young Adult
12
2021
12438
0.210
Why?
Pregnancy
11
2023
6412
0.210
Why?
Squalene
3
2017
7
0.200
Why?
Complementarity Determining Regions
1
2002
49
0.200
Why?
Drug Resistance, Viral
2
2016
110
0.190
Why?
CD4 Lymphocyte Count
4
2017
267
0.190
Why?
Half-Life
1
2021
162
0.180
Why?
Growth Differentiation Factor 15
1
2021
40
0.180
Why?
Mitochondrial Diseases
1
2021
90
0.180
Why?
Immunization Schedule
2
2018
197
0.180
Why?
T-Lymphocytes
2
2009
1935
0.170
Why?
Drug Therapy, Combination
4
2017
1037
0.170
Why?
Fibroblast Growth Factors
1
2021
169
0.170
Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2002
336
0.170
Why?
RNA, Small Untranslated
1
2020
15
0.170
Why?
env Gene Products, Human Immunodeficiency Virus
2
2017
15
0.170
Why?
Hydrophobic and Hydrophilic Interactions
1
2020
185
0.160
Why?
Cytokines
2
2021
2018
0.160
Why?
Body Temperature
1
2020
214
0.150
Why?
Point Mutation
1
2020
224
0.150
Why?
Insulin Resistance
3
2019
1168
0.150
Why?
Immunologic Memory
2
2021
349
0.150
Why?
Haemophilus Vaccines
2
2018
28
0.150
Why?
Immunocompromised Host
2
2000
199
0.150
Why?
Metabolic Syndrome
1
2021
335
0.140
Why?
CD8-Positive T-Lymphocytes
2
2011
855
0.140
Why?
Interleukin-12
1
1998
118
0.140
Why?
Darunavir
1
2017
18
0.140
Why?
Mycobacterium Infections, Nontuberculous
2
2012
353
0.140
Why?
Therapeutic Equipoise
1
2017
2
0.140
Why?
Dose-Response Relationship, Drug
1
2021
2013
0.140
Why?
Interferon-gamma
5
2012
773
0.130
Why?
Lymphopoiesis
1
2017
26
0.130
Why?
Immunoglobulin A
2
2017
201
0.130
Why?
Uganda
1
2017
70
0.130
Why?
Antibody Formation
1
2018
291
0.130
Why?
High-Throughput Screening Assays
1
2018
139
0.130
Why?
Receptors, CCR5
1
2017
57
0.130
Why?
CD4-CD8 Ratio
1
2016
22
0.130
Why?
HIV-Associated Lipodystrophy Syndrome
1
2016
12
0.130
Why?
Cohort Studies
8
2025
5423
0.130
Why?
Mothers
3
2017
731
0.130
Why?
Adoption
1
2016
32
0.130
Why?
Virus Latency
1
2016
84
0.120
Why?
Adult
15
2023
35505
0.120
Why?
Continuity of Patient Care
1
2018
276
0.120
Why?
Chickenpox Vaccine
1
2015
71
0.120
Why?
Early Diagnosis
1
2016
234
0.120
Why?
Body Height
2
2017
194
0.120
Why?
Zimbabwe
2
2025
53
0.120
Why?
Gene Products, env
1
1994
6
0.120
Why?
Disease Susceptibility
1
2017
333
0.120
Why?
Haemophilus influenzae type b
1
2014
10
0.110
Why?
Bacterial Capsules
1
2014
28
0.110
Why?
Chickenpox
1
2015
80
0.110
Why?
Antibody Affinity
1
2014
59
0.110
Why?
South Africa
2
2025
193
0.110
Why?
Acquired Immunodeficiency Syndrome
2
2000
228
0.110
Why?
Cote d'Ivoire
2
2025
9
0.110
Why?
Parotitis
1
2014
6
0.110
Why?
Vaccines, Synthetic
4
2005
125
0.110
Why?
Developing Countries
1
2016
282
0.110
Why?
Lipids
1
2017
614
0.110
Why?
Cytotoxicity, Immunologic
3
2002
220
0.110
Why?
Puberty, Delayed
1
2013
5
0.110
Why?
Intestines
1
2017
350
0.110
Why?
Leukocytes, Mononuclear
4
2013
546
0.110
Why?
Retrospective Studies
8
2023
14532
0.110
Why?
Vaccines
1
2018
400
0.100
Why?
RNA-Directed DNA Polymerase
1
1993
34
0.100
Why?
Patient Selection
1
2017
659
0.100
Why?
Mycobacterium chelonae
1
1993
8
0.100
Why?
Breast Neoplasms
1
2025
2101
0.100
Why?
Lamivudine
3
2023
61
0.100
Why?
Mitochondria
2
2021
876
0.100
Why?
Cell Movement
1
2017
942
0.100
Why?
Child Development
1
2017
458
0.100
Why?
Pediatric Obesity
1
2019
573
0.100
Why?
Clinical Trials as Topic
1
2017
1001
0.100
Why?
Cardiovascular Diseases
2
2016
1997
0.100
Why?
Prospective Studies
4
2017
7150
0.090
Why?
STAT1 Transcription Factor
1
2012
70
0.090
Why?
Body Weight
2
2017
941
0.090
Why?
Polysorbates
3
2017
40
0.090
Why?
Body Fat Distribution
1
2011
48
0.090
Why?
Mycobacterium avium Complex
1
2012
88
0.090
Why?
Epitopes
2
2022
473
0.090
Why?
United States
9
2023
13865
0.090
Why?
Cost-Benefit Analysis
2
2025
566
0.090
Why?
Biomedical Research
1
2017
639
0.090
Why?
Research Design
1
2017
1043
0.090
Why?
Exercise
1
2021
1931
0.080
Why?
Respiratory Tract Infections
1
2014
376
0.080
Why?
Interleukin-2
2
2003
437
0.080
Why?
Prenatal Exposure Delayed Effects
1
2016
572
0.080
Why?
Freezing
1
2009
87
0.080
Why?
Absorptiometry, Photon
2
2025
246
0.080
Why?
Blood
1
2009
105
0.080
Why?
Algorithms
1
2016
1614
0.080
Why?
Staff Development
1
2009
55
0.070
Why?
Phenotype
1
2017
3058
0.070
Why?
Age Factors
4
2019
3150
0.070
Why?
Longitudinal Studies
3
2025
2724
0.070
Why?
Biomarkers
4
2021
3968
0.070
Why?
T-Lymphocyte Subsets
2
2002
412
0.070
Why?
Specimen Handling
1
2009
163
0.070
Why?
Lymphocyte Subsets
2
2009
84
0.070
Why?
Enzyme-Linked Immunosorbent Assay
2
2021
836
0.070
Why?
Faculty
1
2009
138
0.070
Why?
Withholding Treatment
1
2008
71
0.070
Why?
Adipose Tissue
1
2011
594
0.070
Why?
Enterovirus A, Human
1
2007
12
0.070
Why?
Polymerase Chain Reaction
4
2011
1031
0.060
Why?
Central Nervous System Viral Diseases
1
2007
73
0.060
Why?
Flow Cytometry
3
2009
1158
0.060
Why?
DNA, Viral
2
2000
347
0.060
Why?
Academic Medical Centers
1
2009
478
0.060
Why?
False Negative Reactions
1
2025
52
0.060
Why?
Cell Line
3
2012
2774
0.060
Why?
Isoantigens
1
1984
14
0.060
Why?
Medical Audit
1
2025
73
0.060
Why?
Enterovirus Infections
1
2007
171
0.060
Why?
C-Reactive Protein
2
2021
400
0.060
Why?
Colorado
3
2023
4403
0.060
Why?
Immunity, Cellular
1
2006
265
0.060
Why?
Follow-Up Studies
3
2021
4891
0.060
Why?
Disease Outbreaks
1
2007
349
0.060
Why?
Linear Models
2
2020
818
0.060
Why?
Comorbidity
2
2021
1548
0.050
Why?
Confusion
1
2024
28
0.050
Why?
Sequence Analysis, DNA
2
2007
776
0.050
Why?
Thymus Gland
1
1984
309
0.050
Why?
Risk Factors
4
2021
9779
0.050
Why?
Tablets
1
2023
34
0.050
Why?
Constriction, Pathologic
1
2024
234
0.050
Why?
Regression Analysis
2
2021
994
0.050
Why?
Respiratory Syncytial Viruses
1
2022
52
0.050
Why?
Genes, T-Cell Receptor beta
1
2002
21
0.050
Why?
Immunophenotyping
2
1994
310
0.050
Why?
Zidovudine
2
2015
78
0.050
Why?
Clone Cells
1
2002
262
0.050
Why?
Dose-Response Relationship, Immunologic
1
2001
82
0.050
Why?
Cough
1
2022
117
0.050
Why?
Emtricitabine
1
2023
168
0.050
Why?
Vaccines, Subunit
1
2001
48
0.050
Why?
Pyridones
1
2023
158
0.050
Why?
Tenofovir
1
2023
232
0.050
Why?
Lung
1
2014
3928
0.040
Why?
Clinical Trials, Phase I as Topic
1
2021
51
0.040
Why?
Public Health Surveillance
1
2021
68
0.040
Why?
Ganciclovir
1
2000
52
0.040
Why?
Computer Simulation
1
2005
937
0.040
Why?
Adjuvants, Immunologic
2
2017
222
0.040
Why?
Africa
1
2020
99
0.040
Why?
Cross-Sectional Studies
3
2021
5078
0.040
Why?
Injections, Subcutaneous
1
2020
146
0.040
Why?
Sex Factors
2
2019
1966
0.040
Why?
Diagnostic Tests, Routine
1
2021
103
0.040
Why?
Symptom Assessment
1
2021
125
0.040
Why?
HIV Seronegativity
1
2019
25
0.040
Why?
HLA-D Antigens
1
1999
34
0.040
Why?
Risk
1
2021
857
0.040
Why?
Case-Control Studies
2
2019
3383
0.040
Why?
Prevalence
2
2016
2561
0.040
Why?
Cytomegalovirus Infections
1
2000
190
0.040
Why?
Lymphocyte Culture Test, Mixed
1
1998
50
0.040
Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2018
25
0.040
Why?
Cytotoxicity Tests, Immunologic
1
1998
41
0.040
Why?
Vaccines, Combined
1
2018
48
0.040
Why?
Hospitals
1
2023
649
0.040
Why?
Cholesterol, HDL
1
2019
197
0.040
Why?
Amino Acid Sequence
1
2002
2055
0.040
Why?
Mutation
3
2018
3702
0.040
Why?
Poliovirus Vaccine, Inactivated
1
2018
28
0.040
Why?
Odds Ratio
1
2021
1018
0.040
Why?
Hepatitis B Vaccines
1
2018
47
0.040
Why?
Drug Resistance, Microbial
2
2000
69
0.040
Why?
Molecular Sequence Data
1
2002
2827
0.040
Why?
Nutrition Surveys
1
2019
260
0.040
Why?
Case Management
1
2018
63
0.030
Why?
Antigens, Viral
1
1998
179
0.030
Why?
Cholesterol
1
2019
399
0.030
Why?
Cholesterol, LDL
1
2019
349
0.030
Why?
Epitopes, T-Lymphocyte
1
1998
186
0.030
Why?
Reproducibility of Results
1
2005
3081
0.030
Why?
Disease Management
1
2021
591
0.030
Why?
Immune Tolerance
1
1999
356
0.030
Why?
Treatment Adherence and Compliance
1
2017
24
0.030
Why?
Triglycerides
1
2019
514
0.030
Why?
Lymphocyte Count
2
2009
148
0.030
Why?
Cell Division
1
1998
787
0.030
Why?
Uncertainty
1
2017
122
0.030
Why?
Treatment Failure
1
2017
339
0.030
Why?
Multicenter Studies as Topic
1
2017
287
0.030
Why?
Nevirapine
1
2015
17
0.030
Why?
Time-to-Treatment
1
2017
178
0.030
Why?
Randomized Controlled Trials as Topic
1
2021
1368
0.030
Why?
Seroepidemiologic Studies
1
2015
157
0.030
Why?
Maternal Exposure
1
2017
177
0.030
Why?
Malnutrition
1
2016
79
0.030
Why?
Patient Outcome Assessment
1
2016
126
0.030
Why?
Genes, pol
1
1994
7
0.030
Why?
Treatment Outcome
2
2021
10232
0.030
Why?
Antiviral Agents
1
2000
719
0.030
Why?
Coinfection
1
2016
131
0.030
Why?
Neutropenia
1
2015
137
0.030
Why?
Vaccines, Conjugate
1
2014
63
0.030
Why?
Counseling
1
2018
383
0.030
Why?
Sexual and Gender Minorities
1
2018
196
0.030
Why?
Global Health
1
2017
328
0.030
Why?
Cells, Cultured
2
2008
4087
0.030
Why?
Anemia
1
2015
161
0.030
Why?
Maternal-Fetal Exchange
1
2014
162
0.030
Why?
Electron Transport Complex IV
1
2013
57
0.030
Why?
Electron Transport Complex I
1
2013
39
0.030
Why?
Thrombocytopenia
1
2015
189
0.030
Why?
Tuberculosis, Cutaneous
1
1993
3
0.030
Why?
HIV Reverse Transcriptase
1
1993
30
0.030
Why?
Radiography, Thoracic
1
2014
165
0.030
Why?
CD8 Antigens
1
1993
75
0.030
Why?
Severity of Illness Index
1
2021
2734
0.030
Why?
CD3 Complex
1
1993
102
0.020
Why?
Drug Administration Schedule
2
2008
763
0.020
Why?
Lymphocytes
1
1994
377
0.020
Why?
Oxidative Phosphorylation
1
2013
187
0.020
Why?
Medication Adherence
1
2017
560
0.020
Why?
Blood Pressure
1
2019
1735
0.020
Why?
DNA, Mitochondrial
1
2013
190
0.020
Why?
Blood Transfusion
1
1994
298
0.020
Why?
P-Selectin
1
2011
27
0.020
Why?
Antigens, CD
1
1994
485
0.020
Why?
E-Selectin
1
2011
55
0.020
Why?
Heteroduplex Analysis
1
2011
1
0.020
Why?
Tuberculosis, Pulmonary
1
1993
135
0.020
Why?
Hospitalization
1
2021
2076
0.020
Why?
Chemokine CCL2
1
2011
117
0.020
Why?
Cell Proliferation
2
2009
2367
0.020
Why?
Hyperlipidemias
1
2011
118
0.020
Why?
Fibrinogen
1
2011
164
0.020
Why?
Protein Multimerization
1
2012
179
0.020
Why?
Interferon-alpha
1
2012
194
0.020
Why?
Nontuberculous Mycobacteria
1
1993
204
0.020
Why?
Cross Infection
1
1993
219
0.020
Why?
Healthcare Disparities
1
2017
579
0.020
Why?
Cell Adhesion Molecules
1
2011
173
0.020
Why?
Infant, Premature
1
1994
541
0.020
Why?
Diagnosis, Differential
1
2014
1422
0.020
Why?
Pokeweed Mitogens
1
2009
7
0.020
Why?
L-Selectin
1
2009
25
0.020
Why?
Human Experimentation
1
2009
12
0.020
Why?
Tetanus
1
2009
25
0.020
Why?
Candida
1
2009
37
0.020
Why?
Leukocyte Common Antigens
1
2009
82
0.020
Why?
Obesity
1
2021
2875
0.020
Why?
Multivariate Analysis
1
2011
1491
0.020
Why?
Meningitis, Aseptic
1
2007
13
0.020
Why?
Virus Cultivation
1
2007
28
0.020
Why?
Interleukin-6
1
2011
724
0.020
Why?
Phosphorylation
1
2012
1714
0.020
Why?
Data Interpretation, Statistical
1
2009
337
0.020
Why?
Pregnancy Outcome
1
2010
391
0.020
Why?
Cerebrospinal Fluid
1
2007
92
0.020
Why?
Paralysis
1
2007
68
0.020
Why?
Multiple Organ Failure
1
2007
123
0.020
Why?
B-Lymphocytes
1
2012
816
0.020
Why?
Kinetics
1
2010
1641
0.020
Why?
Genotype
1
2011
1827
0.020
Why?
Respiratory System
1
2007
155
0.020
Why?
Immunoglobulin A, Secretory
1
2005
9
0.020
Why?
Cell Survival
1
2009
1084
0.020
Why?
Phosphates
1
1987
181
0.020
Why?
Muscles
1
1987
320
0.020
Why?
Encephalitis
1
2007
131
0.020
Why?
Gastrointestinal Tract
1
2007
186
0.010
Why?
Mucous Membrane
1
2005
125
0.010
Why?
Chemistry, Physical
1
1984
37
0.010
Why?
Antigen-Antibody Reactions
1
1984
54
0.010
Why?
Chemical Phenomena
1
1984
82
0.010
Why?
DNA-Binding Proteins
1
2012
1438
0.010
Why?
Myasthenia Gravis
1
1984
20
0.010
Why?
Tomography, X-Ray Computed
1
2014
2503
0.010
Why?
Immunologic Deficiency Syndromes
1
1984
64
0.010
Why?
Saliva
1
2005
212
0.010
Why?
Tissue Distribution
1
1984
315
0.010
Why?
Aging
2
2003
1770
0.010
Why?
Blood Glucose
1
2013
2071
0.010
Why?
Epithelium
1
1984
311
0.010
Why?
Middle Aged
2
2020
31087
0.010
Why?
Body Mass Index
1
2011
2269
0.010
Why?
Anti-Bacterial Agents
1
1993
1708
0.010
Why?
Infusions, Intravenous
1
2003
402
0.010
Why?
Reference Values
1
2003
795
0.010
Why?
Mice, Inbred BALB C
1
1984
1248
0.010
Why?
Suspensions
1
2000
36
0.010
Why?
Capsules
1
2000
42
0.010
Why?
Urban Population
1
2003
442
0.010
Why?
Drug Tolerance
1
2000
89
0.010
Why?
Cytomegalovirus
1
2000
154
0.010
Why?
Signal Transduction
1
2012
4916
0.010
Why?
Administration, Oral
1
2000
783
0.010
Why?
Epithelial Cells
1
1984
1061
0.010
Why?
Immunization
1
2000
410
0.010
Why?
Time Factors
1
2008
6530
0.010
Why?
Macrophages
1
1984
1486
0.010
Why?
Recombinant Proteins
1
2000
1311
0.010
Why?
Mice
1
1984
16973
0.000
Why?
Tail
1
1987
28
0.000
Why?
Phosphocreatine
1
1987
43
0.000
Why?
Salamandridae
1
1987
27
0.000
Why?
Animals
2
1987
35334
0.000
Why?
Aged
1
1984
22063
0.000
Why?
Magnetic Resonance Spectroscopy
1
1987
541
0.000
Why?
Adenosine Triphosphate
1
1987
475
0.000
Why?
McFarland's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)